A Phase 1 human clinical trial to treat chronic spinal cord injury, the first of its kind in the world,...
A clinical trial to test the efficacy and safety of the transplantation of nasal cells to treat chronic spinal cord...
A Phase I human clinical trial is set to commence to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury.
A state-of-the-art livecyte microscope at the Griffith Institute for Drug Discovery is leading the Spinal Injury Project team toward human clinical trials.
Griffith University’s world-first study into cell transplantation to repair injuries to the nervous system has received a major boost thanks to a $5.4 million funding extension from the MAIC.
Three Griffith University research projects have been successful in gaining grants from the Medical Research Future Fund (MRFF).
Griffith University is seeking five people living with spinal cord injury to be part of stage two of an innovative trial which will test intensive rehabilitation for those living with chronic spinal cord paralysis.
An Australian-first rehabilitation trial considered the next crucial step in treating paralysis will proceed after a record donation from the country’s leading spinal injury research foundation.
A team of Griffith University researchers has won the prestigious Marshall and Warren Innovation Award at the annual NHMRC Research Excellence Awards.
World-leading Griffith research into the development of a cell-based therapy for treating spinal cord injuries has received a $5.7m boost from the state government.
